Both in Pharmaceuticals
Jupiter Neurosciences vs Mustang Bio
Over the past year JUNS returned −97.4% and MBIO returned −67.4%; their daily moves had a correlation of -0.07.
JUNS −97.4% MBIO −67.4%Growth of $1, one year, split-adjusted
| Metric | JUNS | MBIO |
|---|---|---|
| Price | $2.46 | $0.4138 |
| Market cap | $3.2M | $3.1M |
| Today | +1.23% | +1.07% |
| 1 month | −14.0% | −10.0% |
| 6 months | −91.0% | −44.6% |
| Year to date | −96.8% | −57.8% |
| 1 year | −97.5% | −70.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | 86.9% | — |
| Net margin | −9380.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 50.1× | — |
| Net cash | -$6.6K | $15.2M |
| Dividend yield | — | — |
| Volatility (60d) | 128.2% | 49.6% |
| Short % of float | 6.0% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).